Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label adalimumab in Japanese subjects with active ankylosing spondylitis
jRCT2080220558Phase 3
- Sponsor
- Abbott Laboratories
- Start
- May 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in ankylosing spondylitis (AS), sponsored by Abbott Laboratories.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on jRCT2080220558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220558.